115 related articles for article (PubMed ID: 38346386)
21. Folate-functionalized assembly of low density lipoprotein/sodium carboxymethyl cellulose nanoparticles for targeted delivery.
Liang H; He L; Zhou B; Li B; Li J
Colloids Surf B Biointerfaces; 2017 Aug; 156():19-28. PubMed ID: 28499201
[TBL] [Abstract][Full Text] [Related]
22. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes.
Wen S; Liu H; Cai H; Shen M; Shi X
Adv Healthc Mater; 2013 Sep; 2(9):1267-76. PubMed ID: 23447549
[TBL] [Abstract][Full Text] [Related]
23. pH-responsive mechanism of a deoxycholic acid and folate comodified chitosan micelle under cancerous environment.
Chen D; Song P; Jiang F; Meng X; Sui W; Shu C; Wan LJ
J Phys Chem B; 2013 Feb; 117(5):1261-8. PubMed ID: 23311609
[TBL] [Abstract][Full Text] [Related]
24.
Mortezazadeh T; Gholibegloo E; Khoobi M; Alam NR; Haghgoo S; Mesbahi A
J Drug Target; 2020 Jun; 28(5):533-546. PubMed ID: 31842616
[No Abstract] [Full Text] [Related]
25. Folic Acid-Chitosan Oligosaccharide Conjugates Decorated Nanodiamond as Potential Carriers for the Oral Delivery of Doxorubicin.
Liu D; Su Y; Chen J; Pan H; Pan W
AAPS PharmSciTech; 2023 Mar; 24(4):86. PubMed ID: 36964428
[TBL] [Abstract][Full Text] [Related]
26. Folate modified dual pH/reduction-responsive mixed micelles assembled using FA-PEG-PDEAEMA and PEG-SS-PCL for doxorubicin delivery.
Yang C; Wang D; Liu W; Yang Z; He T; Chen F; Lin W
Phys Chem Chem Phys; 2023 May; 25(17):12458-12468. PubMed ID: 37096448
[TBL] [Abstract][Full Text] [Related]
27. Enhanced Cellular Internalization and On-Demand Intracellular Release of Doxorubicin by Stepwise pH-/Reduction-Responsive Nanoparticles.
Li F; Chen WL; You BG; Liu Y; Yang SD; Yuan ZQ; Zhu WJ; Li JZ; Qu CX; Zhou YJ; Zhou XF; Liu C; Zhang XN
ACS Appl Mater Interfaces; 2016 Nov; 8(47):32146-32158. PubMed ID: 27933846
[TBL] [Abstract][Full Text] [Related]
28. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery.
Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L
Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720
[TBL] [Abstract][Full Text] [Related]
29. Delivery of Doxorubicin for Human Cervical Carcinoma Targeting Therapy by Folic Acid-Modified Selenium Nanoparticles.
Xia Y; Xu T; Zhao M; Hua L; Chen Y; Wang C; Tang Y; Zhu B
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428576
[TBL] [Abstract][Full Text] [Related]
30. [Synthesis of folate modified chitosan-based nanomicelles and its
Liu L; Huang G; Bai H; Tang G
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(3):364-374. PubMed ID: 32762172
[TBL] [Abstract][Full Text] [Related]
31. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
[TBL] [Abstract][Full Text] [Related]
32. Cellular uptake and antitumor activity of DOX-hyd-PEG-FA nanoparticles.
Ye WL; Du JB; Zhang BL; Na R; Song YF; Mei QB; Zhao MG; Zhou SY
PLoS One; 2014; 9(5):e97358. PubMed ID: 24828815
[TBL] [Abstract][Full Text] [Related]
33. Folate-decorated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting delivery: optimization and in vivo antitumor activity.
Zhang C; Zhang Z; Zhao L
Drug Deliv; 2016 Jun; 23(5):1830-7. PubMed ID: 26652055
[TBL] [Abstract][Full Text] [Related]
34. Stepwise pH/reduction-responsive polymeric conjugates for enhanced drug delivery to tumor.
Yang S; Wang Y; Ren Z; Chen M; Chen W; Zhang X
Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():234-243. PubMed ID: 29025653
[TBL] [Abstract][Full Text] [Related]
35. pH-responsive selenium nanoparticles stabilized by folate-chitosan delivering doxorubicin for overcoming drug-resistant cancer cells.
Luesakul U; Puthong S; Neamati N; Muangsin N
Carbohydr Polym; 2018 Feb; 181():841-850. PubMed ID: 29254044
[TBL] [Abstract][Full Text] [Related]
36. Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy.
Bi D; Zhao L; Yu R; Li H; Guo Y; Wang X; Han M
Drug Deliv; 2018 Nov; 25(1):564-575. PubMed ID: 29457518
[TBL] [Abstract][Full Text] [Related]
37. Folate-mediated magnetic and pH/GSH dual-responsive metal-polymer-coordinated nanocomplexes for joint chemo/chemodynamic anti-breast cancer therapy.
Lan Z; Tan X; Chen C; Cao Y; Wan Y; Feng S
J Biomater Sci Polym Ed; 2023 Oct; 34(15):2041-2059. PubMed ID: 37104876
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo Evaluation of Folic Acid Modified DOX-Loaded
Deng H; Wang Y; Zhou Y; Zhai D; Chen J; Hao S; Chen X
Int J Nanomedicine; 2023; 18():2003-2015. PubMed ID: 37077940
[TBL] [Abstract][Full Text] [Related]
39. Folate-Conjugated Polyphosphoester with Reversible Cross-Linkage and Reduction Sensitivity for Drug Delivery.
Cao Y; He J; Liu J; Zhang M; Ni P
ACS Appl Mater Interfaces; 2018 Mar; 10(9):7811-7820. PubMed ID: 29431989
[TBL] [Abstract][Full Text] [Related]
40. Development of novel biofunctionalized chitosan decorated nanocochleates as a cancer targeted drug delivery platform.
Bothiraja C; Rajput N; Poudel I; Rajalakshmi S; Panda B; Pawar A
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):447-461. PubMed ID: 29368543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
